When was SCRI International founded?

SCRI International was founded in 2013.

Where is SCRI International located?

SCRI International is headquartered in Cocoa Beach, United States.

How many employees does SCRI International have?

As of Apr 30, 2026, the latest employee count at SCRI International is 2.

Is SCRI International a funded company?

SCRI International is a funded company, having raised a total of $***** in its 1st and only funding round.

Where does SCRI International rank among its competitors?

SCRI International ranks 16th amongst 105 active competitors, of which 13 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Tharimmune, which secured $545M in Nov, 2025.

Who are the top competitors of SCRI International?

SCRI International's top competitors include OnCusp, CancerVax and Linical. Among them, Tharimmune secured the most recent funding round in November, 2025.

SCRI International - 2026 Company Profile & Competitors

Company Details

Provider of oncology clinical research services, including site and data management. The organization offers clinical trial site management and contract research services for biopharmaceutical companies. It delivers operational, regulatory, and centralized research support services for industry-sponsored and investigator-initiated trials. The organization's contract research organization specializes in oncology clinical development services from initial studies to regulatory approval.

Key Metrics

Founded Year

2013

Location

Cocoa Beach, United States

Stage

Unfunded

Ranked

16^th among 105 active competitors

Employee Count

2 as on Apr 30, 2026

Similar Companies

OnCusp & 117 more

View SCRI International's full profile

SCRI International has not raised any funding rounds yet.

SCRI International's employee count trend

SCRI International has 2 employees as of Apr 26. Here is SCRI International's employee count trend over the years:

Employee count trend for SCRI International

Uncover SCRI International's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of SCRI International include OnCusp, CancerVax and Linical. Here is the list of Top 10 competitors of SCRI International, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	OnCusp 2021, New York City (United States), Series A	CRO offering clinical development services for oncology drugs	$139M	Orbimed, Novo Holdings & 8 others	55/100
2nd	CancerVax 1998, Carlsbad (United States), Series B	Limited information available	$58M	Athenian Venture Partners, endpointgroup.com ... & 11 others	50/100
3rd	Linical 2005, Osaka (Japan), Public	Full service CRO with presence in 20+ countries	-	Japan Asia Investment, SBIC West Japan	48/100
4th	Tharimmune 2023, Bridgewater (United States), Public	Clinical-stage biotechnology company developing a portfolio of therapeutic candidates for rare, inflammatory, and oncologic conditions	-	DRW Trading Group, Liberty City Ventures ... & 25 others	47/100
5th	Oncotherapeutics 1988, West Hollywood (United States), Acquired	CRO focused on community oncology research, improving cancer therapies' clinical utility	$8.3M	Domain Associates, TVM Capital	44/100
6th	Medivir 1998, Sweden, Public	Medivir - Science working wonders	-	-	41/100
7th	Vivia Biotech 2007, Tres Cantos (Spain), Series A	Developer of precision medicine test for hematologic cancers	$7.52M	Suanfarma, Clave	39/100
8th	Medelis 2003, Nashville (United States), Acquired	Oncology CRO providing expert clinical trial management for drug development	-	-	39/100
9th	EmeritusDX 2020, Irvine (United States), Unfunded	CRO focused on providing cancer drug development services	-	-	38/100
10th	Aster Insights 2006, Tampa (United States), Series C	Provider of contract based oncology clinical trial services	$75M	Clayton Dubilier & Rice, Hearst & 6 others	37/100
16th	SCRI International 2013, Cocoa Beach (United States), Unfunded	Provider of oncology clinical research services, including site and data management	-	-	33/100